Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma
- PMID: 3150461
- PMCID: PMC2625865
Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma
Abstract
A 59-year-old woman was admitted to the hospital with ovarian carcinoma. After cytoreductive surgery, the patient developed intra-abdominal sepsis. After 17 days of intravenous imipenem, the patient's sputum culture grew imipenem-resistant Pseudomonas aeruginosa. On the 21st day of treatment with imipenem, her peritoneal culture also grew imipenem-resistant Pseudomonas aeruginosa.
Similar articles
-
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.Infect Control Hosp Epidemiol. 2006 Sep;27(9):893-900. doi: 10.1086/507274. Epub 2006 Aug 21. Infect Control Hosp Epidemiol. 2006. PMID: 16941312
-
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.Infect Control Hosp Epidemiol. 2009 May;30(5):487-90. doi: 10.1086/596781. Infect Control Hosp Epidemiol. 2009. PMID: 19335227
-
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.J Infect. 2009 Apr;58(4):285-90. doi: 10.1016/j.jinf.2009.02.010. Epub 2009 Mar 17. J Infect. 2009. PMID: 19297028
-
Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.J Hosp Infect. 2004 Feb;56(2):111-8. doi: 10.1016/j.jhin.2003.10.020. J Hosp Infect. 2004. PMID: 15019222
-
Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns.Clin Infect Dis. 1997 Nov;25(5):1094-8. doi: 10.1086/516092. Clin Infect Dis. 1997. PMID: 9402364
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical